Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business

What does diminution mean?

May 5, 2023 Check out STAT+

Sponsored By

What's the future of Alzheimer's disease treatment? How do you pivot from a pandemic? And how successful can Wegovy get? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Eli Lilly's investigational medicine for Alzheimer's met its goals in an all-important clinical trial, and we explain the results, their implications, and the backstory of what could be a blockbuster drug. We also discuss the latest news in the life sciences, including a busy week of earnings, a long-awaited FDA approval, and the highlights from STAT's Breakthrough Summit in San Francisco. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser